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Abstract
Background: Published work suggests that some types of endothelial cells undergo apoptosis in response to
ligation of the receptor Fas (CD95, APO1) but other types are resistant. Because heterogeneity among
endothelial cells from different tissues, has been demonstrated, the purpose of this study was to determine, if Fas
ligation and/or activation by human Fas ligand induces apoptosis and caspase activities, in cultured human coronary
artery endothelial cells, and the differences between TNF-a and FAS induced apoptosis in these cells.
Results: Cultured human coronary artery endothelial cells (HCAEC) were exposed to the monoclonal Fas-
activating antibody CH-11, to purified recombinant human Fas ligand, to the Fas-neutralizing antibody ZB4, or to
purified recombinant human TNF-α. Apoptosis was detected by assessment of chromatin condensation and
nuclear fragmentation and by assay of the enzymatic activities of Caspase 1 and Caspase 3 with membrane-
permeable substrates applied to intact cells. Fas protein was detected by immunoblotting of HCAEC lysates.
Apoptosis was induced in HCAEC by purified Fas ligand or by the monoclonal activating antibody CH-11 at
concentrations of 25 or 200 ng/ml, but not by nonspecific isotype-matched immunoglobulins. The apoptotic index
elicited by either Fas activator was equal to that induced by TNF-a (3.0-3.6-fold versus control, p < 0.01). The
Fas-neutralizing antibody ZB4 abrogated HCAEC apoptosis induced by CH-11, but had no inhibitory effect on
apoptosis in response to TNF-a. Fas ligation significantly increased the activities of both Caspase 1 and Caspase
3 at 20 hours of stimulation (1.7- and 2.0-fold versus control, both p < 0.05); in contrast, purified TNF-a increased
the activity of Caspase 3 but not Caspase 1 (2.1-fold, p < 0.05). Western blotting of HCAEC lysates with antibody
CH-11 identified a single immunoreactive protein of 90 kDa.
Conclusions: Cultured human coronary artery endothelial cells express functional Fas capable of inducing
apoptosis in response to either purified Fas ligand or receptor-activating monoclonal antibodies, at levels equal
to those inducible by purified TNF-α. Immunologic studies and differential kinetics of caspase activation suggest
that Fas and TNF-α induce apoptosis in HCAEC by signaling pathways that are distinct but equal in potency.
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Background
The vascular endothelium regulates vascular function and
homeostasis [1,2]. Injury to the human coronary artery
endothelium may increase vascular permeability, blood
coagulation, deposition of lipids, smooth muscle cells
and monocytes and can facilitate atherosclerotic plaque
development [3]. Apoptosis of endothelial cells has been
observed as a prominent feature of advanced atherosclero-
sis, and has been implicated in the pathophysiology of
acute coronary syndromes [4-6]. This concept is sup-
ported by the findings of increased expression of Caspase
1/interleukin-1β converting enzyme (ICE) and Caspase 3/
CPP-32 in atherosclerotic tissues [4-7]. Recently, it was
shown [8] that foam cells within coronary arteries of
patients with chronic ischemic heart disease express Fas
(Apo1, CD95), a member of the tumor necrosis factor/
nerve growth factor receptor family that induces apoptosis
independent of TNF-α [9].
Previous work in endothelial cells have led to discordant
reports of sensitivity or resistance to Fas induced apopto-
sis [10-14]. However, heterogeneity among endothelial
cells from different tissues has been demonstrated and the
effect of Fas on human coronary endothelial cells has not
been extensively examined [15-17]. Moreover, in vitro
observations suggest that the regulation of apoptosis in a
vessel may be dependent not only on the cell type but on
the local environment [12,18].
On this basis, we hypothesized that endothelial cells from
different organs may respond differently to regulators of
apoptosis as a result of cell-specific expression of receptors
or downstream signaling molecules. The aim of the
present study was to determine if cultured human coro-
nary artery endothelial cells might undergo apoptosis in
response to Fas activation, in contrast to other endothelial
cell lines [10]. We report herein evidence that the activa-
tion of Fas in cultured human coronary artery endothelial
cells induces apoptosis through signaling mechanisms
distinct from those induced by TNF-α.
Results
Apoptosis of human coronary artery endothelial cells
(HCAEC) was quantitated by fluorescence detection of
chromatin condensation and nuclear fragmentation in
ethanol-fixed cells stained with propidium iodide (Figure
1). The reliability of this assay was confirmed by demon-
stration of the induction of apoptosis of HCAEC by puri-
fied recombinant human TNF-α (Figure 2), which
stimulated apoptosis in a concentration-dependent man-
ner with a maximal induction at 100 pg/ml.
Apoptosis of HCAEC also was induced by either purified
recombinant human Fas ligand (Fas L, Figure 3) or by a
monoclonal antibody (Fas mAB, clone CH-11) known to
activate the receptor in other cell types [15,17]. In con-
trast, a nonspecific isotype-matched control antibody
(N.S.IgM) did not induce apoptosis at the same concen-
tration of 500 pg/ml (Figure 3). By western blotting of
HCAEC lysates, the anti-Fas monclonal antibody CH-11
recognized a single major immunoreactive protein with
molecular mass approximately 90 kDa (Figure 4).
The induction of apoptosis by the CH-11 activating anti-
body (Fas mAB) could be abrogated by the Fas-neutraliz-
ing antibody ZB4 (Figure 5), which blocked about 80% of
the induction of apoptosis by CH-11. However, the ZB4
neutralizing antibody did not inhibit HCAEC apoptosis in
response to purified TNF-α, consistent with the notion
that the induction of apoptosis by the CH-11 Fas-activat-
ing antibody does not involve the TNF receptor in
HCAEC.
The activation of apoptosis with purified TNF-α was
accompanied by a significant increase in the activity of
Caspase 3 (Figure 6), but not in the activity of Caspase 1
measured after 20 hours exposure to the inducer (see
Methods). In contrast, activation of Fas with the CH-11
monoclonal antibody induced significant increases in
both Caspase 3 and Caspase 1 enzymatic activities under
the same assay conditions (Figure 7).
Discussion
Atherosclerosis is an inflammatory disorder, in which
damage to the endothelium is an early causative event [1-
3]. It has been suggested that endothelial cell apoptosis is
an important feature in atherogenesis [4-8]. In support of
this, recent evidence has shown that pro-atherosclerotic
agents like angiotensin II and oxidized LDL induce
endothelial cell apoptosis and that anti atherosclerotic
agents are anti apoptotic [11]. Moreover, increased level
of apoptosis and increased expression of pro apoptotic
factors is observed in endothelial cells found in athero-
sclerotic lesions [23]. However, the apoptotic pathways
that are altered in atherosclerosis have not been clarified.
Fas is a member of the TNF superfamily and is implicated
in the initiation of apoptotic signaling in many tissues. It
has been supported that endothelial cells are resistant to
Fas mediated apoptosis, although other parameters like
the oxidized LDL can sensitize endothelial cell to Fas
apoptosis [10,11]. However, heterogeneity among
endothelial cells from different tissues has been demon-
strated and the effect of Fas on human coronary endothe-
lial cells has not been extensively examined [15-17].
Heterogeneity among endothelial cells in various tissues
has been implicated by both morphologic and functional
studies. For example, endothelial cells isolated from large
versus small vessels were found to vary in the number and
nature of tight junctions and Weibel-Palade bodies [15].BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/6
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Moreover, functional studies have shown that plasma
from patients with idiopathic thrombotic thrombocytic
purpura and hemolytic uremic syndrome induced the
expression of Fas and apoptosis in dermal, renal and cer-
ebral microvascular endothelial cells, but not in cells of
pulmonary origin or in endothelial cells from large vessels
[16,17]. Given these findings, it seems reasonable to sus-
pect that responsiveness to activators of Fas might also
vary with the origin and local environment from which
endothelial cells were isolated.
In the present study, we observed that a monoclonal anti-
body capable of activating human Fas (clone CH-11) and
purified human Fas ligand can induce apoptosis of cul-
tured HCAEC to a degree similar to that induced by puri-
fied human TNF-α. Moreover, the failure of the Fas-
neutralizing antibody ZB4 to abrogate TNF-induced
apoptosis of HCAEC (Figure 5) supports the notion that
Fas induces apoptosis in HCAEC by a mechanism
independent of the TNF receptor. The finding of a differ-
ent profile of activation of caspases 1 and 3 by Fas versus
TNF-α (Figures 6 and 7) is also consistent with this
interpretation.
In any case, the results of the present study are apparently
contradictory to data published by others [10,12], who
reported that Fas ligation does not induce apoptosis in
endothelial cells. We hypothesize that our data, not only
Fluorescence detection of apoptosis in cultured human coronary artery endothelial cells Figure 1
Fluorescence detection of apoptosis in cultured human coronary artery endothelial cells. Human coronary artery endothelial 
cells (HCAEC) were incubated with purified TNF-α (1 ng/ml) in serum-free medium. After 20 hours, the culture vessel was 
centrifuged to retain detached cells and was labeled with propidium iodide (see Materials and Methods). Greyscale image 
depicts red fluorescence (>590 nm) due to chromatin-bound propidium iodide in ethanol-fixed HCAEC treated with DNAse-
free RNAse. Note condensed chromatin in discrete nuclear fragments in apoptotic cells (arrowheads). Arrows depict normal 
nuclei. Bar = 10 microns.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/6
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reflect anatomical and physiological differences in the reg-
ulation of apoptosis among different endothelial cells
subpopulations, but also technical limitations in some of
the studies. The lack of apoptosis in response to Fas liga-
tion shown in some studies [10] may have been due to the
use of antibody preparations which have been shown in
at least one other cell type [19] to be incapable of activat-
ing Fas. Regardless, other authors have reported that Fas
induces apoptosis in endothelial cells [13,23]. Fas protein
expression increases in human coronary endothelial cells
under conditions that promote apoptosis, such as anoxia-
reoxygenation [24,25]. Moreover, Dang et. al [23] found
concurrent apoptosis and Fas expression in the coronary
arteries of transplanted patients with allograft arteriopa-
thy; the Fas-positive cells were primarily endothelial cells.
Other authors have observed strong Fas protein expres-
sion in the smooth muscle cells and endothelial cells of
aortic allografts, and virtually all the apoptotic cells were
located within the area of Fas expression [26].
Apoptosis also has been implicated in cardiomyopathies
and after myocardial infarction, and has also been
observed as a prominent feature in coronary artery disease
associated with atherosclerosis and transplant arteriopa-
thy [4,5,27]. TUNEL-positive endothelial cells also have
been observed in tissues from patients with transplant
coronary arteriopathy and endothelial dysfunction is a
characteristic of chronic heart failure [6]. Together, these
results and our findings support the concept that Fas
expression by endothelial cells may play an important
role in the initiation and progression of pathologies
involving human coronary arteries.
Conclusion
In summary, the present study demonstrates that human
coronary artery endothelial cells express functional Fas
that induces apoptosis to a degree similar to that induced
by TNF-α. Fas in HCAEC is activated by either purified
human Fas ligand or by an activating monoclonal anti-Fas
antibody (clone CH-11), but these activators act in a man-
ner independent of the TNF receptor. These findings sug-
gest functional differences in the responsiveness to
inducers of apoptosis by endothelial cells of different
origins.
Induction of apoptosis in cultured human coronary artery  endothelial cells by purified human TNF-α Figure 2
Induction of apoptosis in cultured human coronary artery 
endothelial cells by purified human TNF-α. Human coronary 
artery endothelial cells (HCAEC) were incubated with puri-
fied recombinant human TNF-α at the indicated concentra-
tions (ng/ml) in serum-free medium. After 20 hours, 
apoptosis was detected as described in Figure 1. Bars are the 
mean + S.E.M. of at least three determinations; ** = p < 0.01 
versus 0.0 dose by ANOVA and Student-Newman-Keul's 
test.
Induction of apoptosis in cultured human coronary artery  endothelial cells by activation of Fas Figure 3
Induction of apoptosis in cultured human coronary artery 
endothelial cells by activation of Fas. Human coronary artery 
endothelial cells (HCAEC) were incubated with purified 
recombinant human Fas ligand (FasL), Fas-activating mono-
clonal antibody CH-11 (Fas mAB), or nonspecific isotype-
matched immunoglobulins (N.S.IgM) at the indicated concen-
trations (ng/ml) in serum-free medium. After 20 hours, apop-
tosis was detected as described in Figure 1. Bars are the 
mean + S.E.M. of at least three determinations; ** = p < 0.01 
versus control (CTL) and * = p < 0.05 versus CTL by 
ANOVA and Student-Newman-Keul's test.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/6
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Methods
Endothelial Cell Culture and Induction of Apoptosis
Primary human coronary artery endothelial cells
(HCAEC, Clonetics Corp, San Diego, CA) were cultured in
cell type-specific culture media optimized for this purpose
(EBM, Clonetics). Cells were seeded on 24-well tissue cul-
ture-treated plates at a density of 5,000 cells per cm2, and
were used at subconfluent densities of 80–90%. Depend-
ing on experimental design, apoptosis was induced with
purified recombinant human tumor necrosis factor-alpha
(TNF-α, Pharmingen, San Diego, CA), with activating
antibodies specific for human Fas (FasmAB clone CH-11,
Upstate Biotechnology, Saranac Lake, NY) or with puri-
fied human recombinant Fas ligand (FasL, Kamiya Bio-
medical, Seattle, WA). All test agents were applied in
serum-free Ham's F12 medium and were applied for 20
hours at 37C in a 5% CO2 incubator.
Fluorescence Detection of Apoptosis
Apoptotic cells were quantitated by detection of chroma-
tin condensation and nuclear fragmentation as described
earlier [19-22]. Briefly, at the end of 20 hours incubation
100% ethanol was added directly to the cell culture vessels
to a final concentration of 70% to fix the cells [19]. After
at least 30 minutes, the culture plates were centrifuged to
retain detached cells, the ethanol was carefully removed,
and a solution of DNAse-free RNAse containing 5 ug/ml
propidium iodide (PI) in PBS was applied and incubated
20 minutes at 37C° to digest RNA. Nuclear morphology
was assessed by the fluorescence of chromatin-bound PI
on a Ziess/Jena Sedival inverted epifluorescence micro-
scope through a >570 nm long pass filter [15,16].
Caspase Assay
The enzymatic activities of Caspase 1/interleukin-1b con-
verting enzyme (ICE) and Caspase 3/CPP32/YAMA were
determined as described earlier for alveolar epithelial cells
Identification of Fas antigen in human coronary artery  endothelial cells Figure 4
Identification of Fas antigen in human coronary artery 
endothelial cells. Cell lysates were prepared from cultured 
HCAEC and were analyzed by western blotting with the 
same anti-Fas monoclonal antibody used for receptor activa-
tion in Figure 3. Note single major immunoreactive band 
(arrowhead). STD = molecular mass standards in kDa.
Fas-neutralizing antibodies abrogate apoptosis of cultured  human coronary artery endothelial cells in response to Fas  but not TNF-α Figure 5
Fas-neutralizing antibodies abrogate apoptosis of cultured 
human coronary artery endothelial cells in response to Fas 
but not TNF-α. Cultured HCAEC were incubated with Fas-
activating monoclonal antibody CH-11 (Fas) or purified 
human TNF-α (TNF) in the presence or absence of the Fas-
neutralizing monoclonal antibody, clone ZB4. Bars are the 
mean + S.E.M. of at least three determinations; ** = p < 0.01 
versus control (CTL) by ANOVA and Student-Newman-
Keul's test.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/6
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[19,20]. Briefly, the enzymes were measured in intact
HCAEC suspension cultures that had been previously
incubated in an identical fashion to those used for
detection of apoptosis. After 18 hours incubation with
activator, the cells were trypsinized from the culture plates
and resuspended in serum-free culture medium contain-
ing activator (anti-Fas or TNF-α) at the same concentra-
tion used for morphologic assay for apoptosis. After one
hour, fluorogenic peptides specific to each enzyme were
added to cuvettes containing the cell suspensions for
determination of total activity in the intact cells. For meas-
urement of Caspase 1/ICE activity, the peptide substrate
N-Acetyl-Tyr-Val-Ala-Asp-7-amino-4-methylcoumarin
(Ac-YVAD-AMC, Pharmingen, San Diego, CA) was used at
final concentration of 50 mM. For Caspase 3/CPP32/
YAMA, the peptide substrate N-Acetyl-Asp-Glu-Val-Asp-7-
amino-4-methylcoumarin (Ac-DEVD-AMC, Upstate Bio-
technology, Saranac Lake, NY) was added at 200 mM final
concentration. Detection of fluorescent product over time
was monitored in a spectroflourometer at 380 nm excita-
tion and 450 nm emission. Data were normalized to
equivalent cell numbers per treatment group, and are
expressed as the intial reaction rates for a given activator
relative to the unactivated control group.
Protein Electrophoresis
Cell lysates were prepared from unactivated HCAEC with
lysis buffer containing the detergent NP40 and a panel pf
protease inhibitors. Protein gel electrophoresis was
performed on 10 ug of HCAEC protein on 7.5% polyacr-
ylamide Ready-Gels (BioRad, Hercules, CA) run under
reducing conditions. Resolved proteins were electrotrans-
fered to PVDF membranes and were subjected to western
blotting with the same monoclonal anti-Fas antibody
used for Fas activation (clone CH-11). Bound antibody
was detected with anti-mouse IgG-biotin secondary
antibody, streptavidin-alkaline phosphatase and Nitro
Blue Tetrazolium (NBT) chromogen.
Statistics
Statistical significance between treatment groups was ana-
lyzed by Analysis of Variance (ANOVA) followed by Stu-
dent Newman Keul's post hoc analysis, through the
Stimulation of Caspase 3 activity in human coronary artery  endothelial cells by purified TNF-α Figure 6
Stimulation of Caspase 3 activity in human coronary artery 
endothelial cells by purified TNF-α. Cultured human coro-
nary artery endothelial cells were incubated for 20 hours in 
the presence and absence of purified recombinant TNF-α 
and were then detached from the culture surfaces. Over the 
subsequent hour, the cells were incubated in suspension cul-
ture with membrane-permeable fluorescent substrates spe-
cific for Caspase 1 (CASP1) and Caspase 3 (CASP3). Data 
are expressed as substrate cleaved per 106 cells, relative to 
unstimulated control cultures (CTL). Bars are the mean + 
S.E.M. of at least three determinations; * = p < 0.05 versus 
unstimulated control (CTL) by ANOVA and Student-New-
man-Keul's test.
Stimulation of Caspase 1 and Caspase 3 activities in human  coronary artery endothelial cells by activation of Fas Figure 7
Stimulation of Caspase 1 and Caspase 3 activities in human 
coronary artery endothelial cells by activation of Fas. Cul-
tured human coronary artery endothelial cells were incu-
bated for 20 hours in the presence and absence of anti-Fas 
clone CH-11 activating antibody, and were then detached 
from the culture surfaces. Over the subsequent hour, the 
activities of Caspase 1 (CASP1) and Caspase 3 (CASP3) were 
determined as described in Figure 6. Data are expressed as 
substrate cleaved per 106 cells, relative to unstimulated con-
trol cultures (CTL). Bars are the mean + S.E.M. of at least 
three determinations; * = p < 0.05 versus unstimulated con-
trol (CTL) by ANOVA and Student-Newman-Keul's test.Publish with BioMed Central    and   every 
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software package Instat (Graphpad Software, San Diego,
CA). Differences were considered significant at p < 0.05.
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